A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 4, 2001, Pages 433-438

  Mutabingwa, T K ^a   Maxwell, C A ^a,b   Sia, I G ^b   Msuya, F H M ^a   Mkongewa, S ^a   Vannithone, S ^b   Curtis, J ^b   Curtis, C F ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Chemotherapy; Children; Dapsone; Drug combinations; Malaria; Plasmodium falciparum; Proguanil; Sulfadoxine pyrimethamine; Tanzania

Indexed keywords

ANTIMALARIAL AGENT; DAPSONE; FANSIDAR; PROGUANIL; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; PILOT STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROGUANIDE; DAPSONE; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PILOT PROJECTS; PYRIMETHAMINE; SULFADOXINE;

EID: 0035409743     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90207-X     Document Type: Article

References (42)

1. Amukoye, E., Winstanley, P. A., Watkins, W. M., Snow, R. H., Hatcher, J., Mosobo, M., Ngumbao, E., Lowe, B., Ton, M., Minyiri, G. & Marsh, K. (1997). Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria. Antimicrobial Agents and Chemotherapy, 41, 2261-2264.
2. Black, R. H. (1973). Malaria in the Australian army in South Vietnam: successful use of a proguanil-dapsone combination for chemoprophylaxis of chloroquine-resistant falciparum malaria. Medical Journal of Australia, 60, 1265-1270.
3. Clyde, D. (1954). Observations on monthly pyrimethamine ('Daraprim') prophylaxis in an East African village. East African Medical Journal, 3, 41-46.
4. Clyde, D. & Shute, G. (1957). Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene, 51, 505-513.
5. Curtis, C. F., Maxwell, C. A., Finch, R. A. & Njunwa, K. J. (1998). A comparison of use of a pyrethroid either for house spraying or for bednet treatment against malaria vectors. Tropical Medicine and International Health, 3, 619-631.
6. Curtis, J., Duraisingh, M. T. & Warhurst, D. C. (1998). In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. Journal of Infectious Diseases, 177, 1429-1433.
7. Draper, C. C., Hills, M., Kilimali, V. A. E. B. & Brubaker, G. (1988). Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986. Journal of Tropical Medicine and Hygiene, 91, 265-273.
8. Edstein, M. D., Yeo, A. E. T., Shanks, G. D. & Rieckmann, K. H. (1997). Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates. Acta Tropica, 66, 127-135.
9. Foote, S. J., Galatis, D. & Cowman, A. F. (1990). Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the USA, 87, 3014-3017.
10. Hellgren, U., Angel, V. H., Bergqvist, Y., Arvidsson, A., Forero-Gomez, J. S. & Rombo, L. (1990). Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 46-49.
11. Herrlin, K., Massele, A. Y., Rimoy, G., Alm, C., Rais, M., Ericsson, O., Bertilsson, L. & Gustafsson, L. L. (2000). Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype. Clinical Pharmacology and Therapeutics, 68, 189-198.
12. Irare, S. G. M., Lemnge, M. M. & Mhina, J. K. (1991). Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania. Tropical and Geographical Medicine, 43, 352-356.
13. Keuter, M., van Eijk, A., Hoogstrate, M., Raasveld, M., van de Ree, M., Ngwawe, W. A., Watkins, W. M., Were, J. M. O. & Brandling-Bennett, A. D. (1990). Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya. British Medical Journal, 301, 466-470.
14. Kilimali, V. A. E. B. & Mkufya, A. R. (1985). In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 482-483.
15. Maxwell, C. A., Myamba, J., Njunwa, K. J., Greenwood, B. M. & Curtis, C. F. (1999). Comparison of bednets impregnated with different pyrethroids for their impact on mosquitoes and on re-infection with malaria after clearance of pre-existing infections with chlorproguanil-dapsone. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 4-11.
16. Msuya, F. H. & Curtis, C. F. (1991). Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 4. Effects on incidence of malaria infection. Acta Tropica, 49, 165-171.
17. Nzila Mounda, A., Mberu, E. K., Sibley, C. H., Plowe, C. V., Winstanley, P. A. & Watkins, W. M. (1998). Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrobial Agents and Chemotherapy, 42, 164-169.
18. Petersen, E., Hogh, B., Hanson, A. P., Bjorkman, A. D. & Flacks, H. (1990). In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil. Annals of Tropical Medicine and Parasitology, 84, 563-571.
19. Peterson, D. S., Milhous, W. K. & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the USA, 87, 3018-3022.
20. Rønn, A. M., Msangeni, H. A., Mhina, J., Wernsdorfer, W. H. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
21. Shanks, G. D., Edstein, M. D., Suriyamongkol, V., Timsaad, S. & Webster, H. K. (1992). Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border. American Journal of Tropical Medicine and Hygiene, 46, 643-648.
22. Skjelbo, E., Mutabingwa, T. K., Bygbjerg, I., Nielsen, K. K., Cram, L. F. & Broosen, K.(1996). Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians. Clinical and Pharmacological Therapeutics, 59, 304-311.
23. Smithurst, B. A. & Robertson, I. (1971). Dapsone-induced agranulocytosis complicated by Gram-negative septicaemia. Medical Journal of Australia, 58, 537-539.
24. Stich, A. H. R., Maxwell, C. A., Haji, A. A., Haji, D. M., Machano, A. Y., Mussa, J. K., Matteelli, A., Haji, H. & Curtis, C. F. (1994). Insecticide-impregnated bed nets reduce malaria transmission in rural Zanzibar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 150-154.
25. Stickland, J. F. & Hurdle, A. D. (1970). Agranulocytosis probably due to dapsone in an infantry soldier. Medical Journal of Australia, 57, 959-960.
26. Thaithong, S., Chan, S. W., Songsomboom, S., Wilairat, P., Seesod, N., Sueblinwong, T., Goman, M., Ridley, R. & Beale, G. (1992). Pyrimethamine resistant mutations in Plasmodium falciparum. Molecular and Biochemical Parasitology, 52, 149-158.
27. Trigg, J. K., Mbwana, H., Chambo, O., Hills, E., Watkins, W. & Curtis, C. F. (1997). Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone. Acta Tropica, 63, 185-189.
28. Warsame, M., Kilimali, V. A. E. B., Wernsdorfer, W. H., Lebbadd, M., Rutta, A. S. & Ericsson, O. (1999). Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 312-313.
29. Watkins, W. (2000). Pyrimethamine-sulfadoxine (PSD) resistant falciparum malaria in East Africa: a disaster in malaria control (Abstract). XV International Congress for Tropical Medicine and Malaria, Cartagena de Indias, Colombia, 20-25 August 2000.
30. Watkins, W. M., Brandling Bennett, A. D., Nevill, C. G., Carter, J. Y., Boriga, D. A., Howells, R. E. & Koech, D. K. (1988). Chlorproguanil/dapsone for the treatment of nonsevere Plasmodium falciparum malaria in Kenya: a pilot study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 398-403.
31. Watkins, W. M., Mberu, E. K., Winstanley, P. A. & Plowe, C. V. (1997). The efficacy of antifolate antimalarials in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analysis. Parasitology Today, 13, 459-464.
32. Weetman, R. M., Boxer, L. A., Brown, M. P., Mantich, N. M. & Baehner, R. L. (1980). In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone. British Journal of Haematology, 45, 361-370.
33. White, N. J. (1985). Clinical pharmacokinetics of anti-malarial drugs. Clinical Pharmacokinetics, 10, 187-215.
34. White, N. J. (1999). Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia, 41, 301-308.
35. WHO (1996). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated Plasmodium falciparum in areas of intense transmission. Geneva, Switzerland: World Health Organization, Division of Control of Tropical Diseases. WHO/MAL/96.1077.
36. Wilairatana, P., Kyle, D. E., Looareesuwan, S., Chinwongprom, S., Amradee, S., White, N. J. & Watkins, W.M. (1997). Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Annals of Tropical Medicine and Parasitology, 91, 125-132.
37. Winstanley, P. A. (2000). Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Parasitology Today, 16, 146-153.
38. Winstanley, P. A., Watkins, W. M., Newton, C. R. J. C., Nevill, C., Warn, P. A., Waruiru, C. M., Mwangi, I. N., Warrell, D. A. & Marsh, K. (1992). The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. British Journal of Clinical Pharmacology, 33, 143-148.
39. Winstanley, P., Watkins, W., Muhia, D., Szwandt, S., Amukoye, E. & Marsh, K. (1997). Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 322-327.
40. Yeo, A. E., Edstein, M. D. & Shanks, G. D. (1992). Proguanil combined with dapsone chemoprophylaxis for malaria. Medical Journal of Australia, 156, 883.
41. Zindrou, S., Dung, N. P., Sy, N. D., Skold, O. & Swedburg, G. (1996). Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient. Experimental Parasitology, 84, 56-64.
42. Zuidema, J., Hilbers Modderman, E. S. & Merkus, F. W. (1986). Clinical pharmacokinetics of dapsone. Clinical Pharmacokinetics, 11, 299-315.